Rachel Stahler

Rachel Stahler

Chief Tech/Sci/R&D Officer at ORGANON & CO.

Net worth: 2 M $ as of 31/08/2026

50 year
Commercial Services
Health Technology
Consumer Services

Profile

Rachel A. Stahler is on the board of NeoGenomics, Inc. and NeoGenomics Laboratories, Inc. In the past she occupied the position of Chief Information Officer for inVentiv Health Clinical, Inc., Chief Information Officer at Optimer Pharmaceuticals LLC, Chief Information Officer at inVentiv Health, Inc. and Chief Information Officer for InVentiv Group Holdings, Inc. She received an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Pennsylvania.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/06/2026 116,524 ( 0.04% ) 2 M $ 31/08/2026

Rachel Stahler active positions

CompaniesPositionStart
ORGANON & CO. Chief Tech/Sci/R&D Officer 01/01/2021
Director/Board Member -

Former positions of Rachel Stahler

CompaniesPositionEnd
NEOGENOMICS, INC. Director/Board Member 26/06/2023
ALLERGAN PLC Chief Investment Officer 01/01/2020
Chief Tech/Sci/R&D Officer 01/01/2019
Chief Tech/Sci/R&D Officer 01/01/2017
Chief Tech/Sci/R&D Officer 01/01/2015
See the detail of Rachel Stahler's experience

Training of Rachel Stahler

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

63

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Services

Commercial Services

Commercial Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Services

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Rachel Stahler